1020 related articles for article (PubMed ID: 22709607)
1. A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; He B; Mylott W; Zhao S; Mariannino T; Shen J; Stouffer B
J Pharm Biomed Anal; 2012 Nov; 70():574-9. PubMed ID: 22709607
[TBL] [Abstract][Full Text] [Related]
2. UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers.
Patel DP; Sharma P; Sanyal M; Singhal P; Shrivastav PS
Biomed Chromatogr; 2013 Aug; 27(8):974-86. PubMed ID: 23483571
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of carvedilol and its metabolites in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and pharmacokinetic application.
Li J; Wang L; Wang S; Chen M; Gu E; Hu G; Ge R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():138-46. PubMed ID: 25463209
[TBL] [Abstract][Full Text] [Related]
4. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
[TBL] [Abstract][Full Text] [Related]
5. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma.
Wang S; Cyronak M; Yang E
J Pharm Biomed Anal; 2007 Jan; 43(2):701-7. PubMed ID: 16959461
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective and sensitive determination of carvedilol in human plasma using chiral stationary-phase column and reverse-phase liquid chromatography with tandem mass spectrometry.
Jiang J; Tian L; Huang Y; Yan Y; Li Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():92-7. PubMed ID: 24792533
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of vortioxetine, carvedilol and its active metabolite 4-hydroxyphenyl carvedilol in rat plasma by UPLC-MS/MS: Application to their pharmacokinetic interaction study.
Huang Y; Zheng S; Pan Y; Li T; Xu ZS; Shao MM
J Pharm Biomed Anal; 2016 Sep; 128():184-190. PubMed ID: 27262994
[TBL] [Abstract][Full Text] [Related]
8. A validated HPLC-MS/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Savant I; Yuan M; Scott L; Mylott W; Mariannino T; Kadiyala P; Roongta V; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():36-41. PubMed ID: 23542721
[TBL] [Abstract][Full Text] [Related]
9. Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study.
Rathod R; Prasad LP; Rani S; Nivsarkar M; Padh H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):219-23. PubMed ID: 17702675
[TBL] [Abstract][Full Text] [Related]
10. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry.
Poggi JC; Da Silva FG; Coelho EB; Marques MP; Bertucci C; Lanchote VL
Chirality; 2012 Mar; 24(3):209-14. PubMed ID: 22271587
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective LC/ESI-MS/MS analysis and pharmacokinetic and tissue distribution study of (2RS)-1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)-propan-2-ol in rats.
Walczak M; Szymura-Oleksia J; Groszek G
Chirality; 2012 Aug; 24(8):591-9. PubMed ID: 22714390
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS assay of quinapril and its metabolite quinaprilat for drug bioequivalence evaluation: prospective, concurrential and retrospective method validation.
Sora I; Cristea E; Albu F; Udrescu S; David V; Medvedovici A
Bioanalysis; 2009 Apr; 1(1):71-86. PubMed ID: 21083190
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization.
Peccinini RG; Ximenes VF; Cesarino EJ; Lanchote VL
Biopharm Drug Dispos; 2008 Jul; 29(5):280-8. PubMed ID: 18551504
[TBL] [Abstract][Full Text] [Related]
14. Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry.
Jeong DW; Kim YH; Ji HY; Youn YS; Lee KC; Lee HS
J Pharm Biomed Anal; 2007 Jun; 44(2):547-52. PubMed ID: 17270380
[TBL] [Abstract][Full Text] [Related]
15. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patients.
Zakrzewski-Jakubiak M; de Denus S; Leblanc MH; White M; Turgeon J
J Pharm Biomed Anal; 2010 Aug; 52(4):636-41. PubMed ID: 20189739
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization.
Yang E; Wang S; Kratz J; Cyronak MJ
J Pharm Biomed Anal; 2004 Nov; 36(3):609-15. PubMed ID: 15522537
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
[TBL] [Abstract][Full Text] [Related]
19. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies.
Zarghi A; Foroutan SM; Shafaati A; Khoddam A
J Pharm Biomed Anal; 2007 May; 44(1):250-3. PubMed ID: 17391893
[TBL] [Abstract][Full Text] [Related]
20. Development of an SPE-LC-MS/MS method for simultaneous quantification of bosentan and its active metabolite hydroxybosentan in human plasma to support a bioequivalence study.
Parekh JM; Shah DK; Sanyal M; Yadav M; Shrivastav PS
J Pharm Biomed Anal; 2012 Nov; 70():462-70. PubMed ID: 22789899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
